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Abstract
Background and aim: Respiratory syncytial virus (RSV) is one of the most important causes of acute lower
respiratory tract infections (ALRTI) in infants and young children. This study was conducted to describe the
epidemiology of ALRTI associated with RSV among children ≤ 5 years old in Egypt.
Patients and Methods: We enrolled 427 children ≤ 5 years old diagnosed with ALRTI attending the outpatient
clinic or Emergency Department (ED) of Children Hospital, Cairo University during a one- year period.
Nasopharyngeal aspirates were obtained from the patients, kept on ice and processed within 2 hours of collection.
Immunoflourescent assay (IFA) for RSV was performed.
Results: 91 cases (21.3%) had viral etiology with RSV antigens detected in 70 cases (16.4%). The RSV positive cases
were significantly younger than other non-RSV cases (mean age 8.2 months versus 14.2 months, p <0.001). RSV
cases had significantly higher respiratory rate in the age group between 2-11 months (mean 58.4 versus 52.7/
minute, p < 0.001) and no significant difference in the mean respiratory rate in the age group between 12-59
months. More RSV cases required supplemental oxygen (46% versus 23.5%, p < 0.001) with higher rate of
hospitalization (37.1% versus 11.2%, p < 0.001) than the non-RSV cases. 97% of RSV cases occurred in winter season
(p < 0.001).
Conclusion: RSV is the most common viral etiology of ALRTI in children below 5 years of age, especially in young
infants below 6 months of age. It is more prevalent in winter and tends to cause severe infection.
Introduction
Viral infections are the most frequent etiological agents
for acute respiratory infections, and are responsible for a
significant morbidity and mortality in children [1].
Respiratory syncytial virus (RSV) is well recognized as
the most important pathogen causing acute respiratory
disease in infants and young children, mainly in the form
of bronchiolitis and pneumonia [2]. Influenza viruses’
type A and B (FLU A/B), parainfluenza virus (PIV), ade-
novirus (ADV), and human metapneumovirus (hMPV)
are other important viral etiologic agents of ALRTI [1].
RSV infection is associated with significant disease
burden in infants and young children in terms of hospi-
talization, related complications, and even mortality [3].
Identification of the etiologic agents of ALRTI and mon-
itoring their trends, in a particular setting, improve
patient management, and guide antimicrobial utilization
and implementation of infection control precautions.
The epidemiology of RSV has not been studied in Egypt
before.
The objective of this study was to describe the epide-
miology and clinical characteristics of ALRTI caused by
RSV among a group of Egyptian children below 5 years
of age and to compare between children infected with
RSV and those that had ALRTI but did not have RSV.
Materials & methods
Patients
We recruited four hundred and twenty seven children
(427) less than five years of age presenting with ALRTI
from the out-patient clinic and emergency department
of Cairo University Children Hospitals over one year
* Correspondence: aya.fattouh@gmail.com
1Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt
Full list of author information is available at the end of the article
Fattouh et al. Italian Journal of Pediatrics 2011, 37:14
http://www.ijponline.net/content/37/1/14 ITALIAN JOURNAL 
OF PEDIATRICS
© 2011 Fattouh et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.between December 2006 and November 2007. We
obtained the pediatric department research review board
approval.
A case of pneumonia was defined; depending on
WHO definitions, as a child with cough and difficult
breathing or tachypnea (50 breaths per minute or more
in a child aged 2-11 months or 40 breaths per minute
or more in a child aged 12-59 months) and if the
patient exhibit lower chest in-drawing or stridor, he will
be diagnosed as a case of severe pneumonia [4]. Those
who are not fast breathing was diagnosed as a case of
bronchitis or wheezing bronchitis. Patients; included
depending on clinical findings, were eligible for inclu-
sion whether they were managed as outpatients or were
hospitalized but those with symptoms longer than four
weeks were excluded.
Following informed parent consent, patients were sub-
jected to a questionnaire detailing demographic data
and past medical history completed by the parents/
guardians.
Full clinical history was obtained including the current
illness with special emphasis on the presence of extra-
pulmonary manifestations as inability to feed or drink,
vomiting, diarrhea, convulsions, altered mental status or
conjunctivitis. The history included data about any
received antibiotic therapy, previous episodes diagnosed
as lower respiratory tract infection and any associated
conditions especially congenital heart disease, asthma,
malnutrition, renal disorders or diabetes. Accurate
gestational age of the included patients could not be
obtained as those patients were selected from the outpa-
tients’ clinic and the ED and their parents did not have
any birth related documents.
Physical examination included general examination
and thorough chest examination to detect the presence
of respiratory distress (tachypnea, chest indrawing,
grunting or cyanosis) and other chest findings as wheez-
ing and crepitations. Chest x-ray and complete blood
count were done for those patients whose conditions
required hospital admission.
Specimens
Nasopharyngeal aspirate samples were collected in ster-
ile vials from each enrolled child. The specimens were
collected between 1–15 days of illness. The sample was
kept on ice and processed within 2 hours of collection
[5]. Immunoflourescent assay (IFA) for RSV, adenovirus,
influenza A virus, influenza B virus, and parainfluenza
1-3 viruses (Panel I Viral Screening and Identification
Kit, Chemicon International, Inc., Temecula, CA) was
performed on each sample.
Blood was collected aseptically using venipuncture
techniques and serum samples were refrigerated at
-70°C. Indirect immuno-enzyme assay (ELISA) was used
to test for IgG and IgM of Chlamydophila and Myco-
plasma using VIRCELL kit (VIRCELL, S.L. Pza.Domin-
guez Ortiz 1.Poligono Industrial Dos de October 18320
Santa Fe, Granada, Spain; lot number 06ECPN107).
Clinical management and outcome data were
collected.
Statistical analysis
Data were statistically described in terms of mean ±
standard deviation (± SD), frequencies (number of
cases) and percentages when appropriate. Comparison
of quantitative variables between the study groups was
done using Student t test for independent samples. For
comparing categorical data, Chi square (c
2) test was
performed. Exact test was used instead when the
expected frequency is less than 5. A probability value
(p value) less than 0.05 was considered statistically sig-
nificant. All statistical calculations were done using
computer programs Microsoft Excel 2003 (Microsoft
Corporation, NY, and USA) and SPSS (Statistical Pack-
age for the Social Science; SPSS Inc., Chicago, IL, USA)
version 15 for Microsoft Windows.
Results
A viral agent was detected in 91 children (21.3%) of the
enrolled cases, 70 children of them (16.4%) were
infected with RSV. The other viruses that were identi-
fied included: para-influenza 3 virus in 14 children
(3.3%); influenza A virus in 3 children (0.7%), adenovirus
in 2 and para-influenza 1 in 2 cases (0.5%). There was
no overlap in infection between the RSV virus and the
other identified viruses.
Among the RSV cases, 34 (48.6%) were males. Their
median age was 3 months (range between 8 days and
4 years) and 45 cases (64%) of them were less than
6 months. Fifty one children (72.8%) had received antibio-
tic therapy for a median of 3 days (range between
1-13 days) before admission. Regarding the clinical diag-
nosis of the RSV cases, 43 patients were diagnosed as
pneumonia (61.4%) while 22 cases were diagnosed as
bronchitis (31.4%) and 5 cases with wheezing bronchitis
(7.1%) Twenty five cases (35.7%) reported having a pre-
existing medical condition; 14 cases (21.2%) were small for
weight, 5 cases (7.1%) had recurrent wheezy chest, 4 cases
(5.7%) suffered from a congenital heart disease, one patient
with chronic renal failure and one with diabetes. They did
not have different outcomes.
Comparing the RSV cases and the remaining 357
patients showed significantly lower mean age of the RSV
cases. The mean weight of the RSV cases was signifi-
cantly lower than the non RSV cases but actually the
non RSV cases with small weight for age were signifi-
cantly more than the RSV cases (21.2% versus 37.8%,
p value 0.024). RSV infection was associated with
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between 2-11 months (58.4 ± 9.2 versus 52.7 ± 9.3,
p <0.001) while in those between 12-59 months
although showed higher respiratory rate but with no sig-
nificant difference (47.7 ± 8.53 versus 46.8 ± 8.48,
p 0.724). Chest in-drawing was significantly more
among the RSV cases. The rate of hospitalization was
significantly higher among RSV cases (26/70 cases
37.1%, compared to 40/357 non-RSV cases 11.2%) with
median days of hospitalization 3 days (range 1 - 15).
Also, significantly more RSV cases required supplemen-
tal oxygen (32/70 compared to 84/357). Only one
patient died in each group and this leads to a signifi-
cantly higher case fatality rate among the RSV cases
(1.4% versus 0.3%, p < 0.001, Odds ratio 5.159, CI 95%=
0.319 -83.483) (Table 1). These two patients had no
underlying diseases or risk factors
On analyzing the data about seasonal distribution of
the RSV cases and the non RSV cases; we found that 68
children (97.1%) of the RSV cases presented during the
3-month-period from December to February. For the
two months of December and January, RSV was the
etiology for 59% of the enrolled ALRTI cases (Figure 1).
Discussion
In the present study, the overall incidence of viral infec-
tion defined by IFA alone on nasopharyngeal specimens
was 21%. The most frequently encountered virus was
RSV (16.4%). The reported rates of RSV in other series
were generally comparable to that reported in the present
study [6-11]. Other studies have used different methods
of viral detection as real-time PCR which resulted in
higher rates of RSV detection up to 44-49% [12,13]. The
different inclusion criteria in the different series contrib-
uted to the different rates of RSV detection as in our
study we included only patients less than 5 years old who
presented with ALRTI while other studies have included
wider range of clinical diagnosis such as upper respira-
tory tract infection and even isolated fever resulting in
higher rate of viral detection [14]. Others who focused on
patients presenting with bronchiolitis or asthmatic
bronchiolitis reported even higher rates of RSV detection
reaching up to 56-72% (8&15). This may be attributed to
the strong association between RSV infection early in life
and the subsequent development of asthma [16]. The
mechanism by which RSV contributes to asthma is com-
plex and remains largely unknown although RSV-infected
patients have increased levels of Th2 cytokines and IgE in
the patients’ sera, suggesting that an allergy-like condi-
tion may develop during infection [17]. In our study,
7.1% of RSV cases were admitted with the diagnosis of
wheezing bronchitis and gave history or recurrent
wheezy chest.
The RSV cases had significantly lower age mean than
the non-RSV cases with 64% of them younger than
6 months old. The young age has been documented as
a risk factor for RSV infection in many studies
[9,10,14,17]. This can be attributed to the lower cellular
immunity [10]. At the same time, this is an age when
maternally acquired antibodies are decreasing with a
Table 1 The clinical characteristics of the RSV vs. non RSV cases
RSV
(n = 70)
Non-RSV (n = 357) P-value
Mean Age ± std. deviation (months) 8.2 (± 11.5) 14.2 (± 14.37) 0.001
Mean Weight ± std. deviation (kg) 6.7(± 3.3) 8.5(± 5.4) 0.006
Patients with small weight for age (%) 21.2% 37.8% 0.024
Mean Respiratory rate ± std. deviation (/min) in patients 2-11 mo 58.4 (± 9.2) 52.7 (± 9.3) <0.001
Mean Respiratory rate ± std. deviation (/min) in patients 12-59 mo 47.7(± 8.53) 46.8(± 8.48) 0.724
Tachypnea (%) 62.9% 54.9% 0.137
Wheezes (%) 7.1% 9.8% 0.635
Difficult breathing (%) 98 91 0.053
Chest in-drawing (%) 88 74 0.014
Cough (%) 100 97 0.18
Inability to feed (%) 52 44 0.13
Convulsions (%) 1.7 3.3 0.4
Past history of pneumonia (%) 14 31 0.003
Supplemental Oxygen (%) 46 23.5 <0.001
Hospitalization (%) 37.1 11.2 <0.001
Admission to ICU (%) 1.5 1.1 0.59
Case fatality rate (%) 1.4 0.3 <0.001
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nitude of the humoral immune response to RSV in chil-
dren <3 months [18].
In our study, we included patients with ALRTI so
cough was a persistent feature in all patients while diffi-
cult breathing was encountered in almost all patients.
We tried to demonstrate any useful association to predict
RSV infection from clinical data and we found that RSV
patients demonstrated higher respiratory rates, especially
in the age group 2-11 months which includes 80% of the
RSV cases; this was also observed by other investigators
[19]. Chest in-drawing was encountered more frequent in
RSV patients. These findings are consistent with Durain
et al. who concluded that cough and retractions are pre-
dictive signals of RSV infection in young infants [20].
Another important feature of RSV infection is the sea-
sonality of RSV infection. In temperate climate, RSV
activity increases in the winter months but may occur
year around in equatorial areas [21-23] while in tropical
and subtropical areas, RSV infection peaks more often in
relation to wet season [24]. In the current study, most
RSV cases (97.1% of cases) occurred mainly between
December and February; which are the cold months of
the year in Egypt. In other countries like Italy, the peak
of the RSV epidemic occurs in February, with an earlier
occurrence and disappearance in the northern and cen-
tral regions, compared to the southern regions [25]. The
study of the local epidemiology of RSV infection is essen-
tial for predicting epidemics and planning for preventive
measures especially for the high risk groups.
RSV infection in our study tended to be severe as
demonstrated by observing the higher hospitalization
rate (3 times greater than other etiologies, p < 0.001)
which is consistent with other series [25-27] and the
greater need to supplemental oxygen. Although the case
fatality rate was significantly higher among the RSV
cases but this may be due to the fact that the number of
deaths are too small to make a clinically significant
comparison.
There are some well-known medical risk factors asso-
ciated with RSV infection as prematurity, chronic lung
disease and congenital heart disease. Congenital heart
disease had been encountered in 5.7% of our RSV cases.
One of the limitations of the current study was the
inability to investigate the other risk factors especially
prematurity due to the fact that our patients were
selected from the outpatient clinic or the ED with lack
of accurate documented information about their gesta-
tional age. We couldn’tr e l yo nt h ed a t ag i v e nb yt h e i r
parents which could have interfered with the accuracy
of our results.
There are other host environmental factors such as
severe stunting which was found to be associated with
increased risk of progression to RSV associated pneu-
monia [28]. In our study, the mean weight in RSV cases
was much lower than other patients but this was attrib-
uted to the lower mean age of the RSV cases.
One of the limitations in the present study was that we
did not investigate the bacterial infection in depth to
accurately identify the need for antibiotic administration.
But we cannot ignore the fact that the majority of RSV
cases (72.8%) have received antimicrobials prior to identi-
fication of a viral etiology and the same percent was
encountered in the non RSV cases (72%). Other studies
have also reported excess antibiotic prescription during
periods of RSV activity [29]; although numerous studies
have shown that the occurrence of a secondary or con-
current bacterial infection in hospitalized children with
RSV lower respiratory tract disease (LRTD) is <1% [30].

























Figure 1 shows the monthly distribution of RSV cases compared to the other cases.
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These findings supports the imperative need for rapid
reliable screening test to detect RSV infection to avoid
unjustified use of antibiotics and also to reinforce imple-
mentation of infection control precautions among hospi-
talized cases, when diagnosis of RSV infection etiology is
established.
IN CONCLUSION, RSV is the most common viral
etiology of ALRTI in children below 5 years of age, espe-
cially among young infants less than 6 months of age.
RSV infection was more often during winter months.
Our results underscore the fact that routine testing chil-
dren with ALRTI for RSV to avoid unnecessary antimi-
crobial therapy and to apply infection prevention and
control precautions. Further studies are required to accu-
rately define the risk groups who are in need for
immunoprophylaxis.
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